Stockscreener 앱 받기
1.34
2.29%
0.03
시간 외 거래:
1.31
-0.03
-2.24%
전일 마감가:
$1.31
열려 있는:
$1.31
하루 거래량:
26,907
Relative Volume:
0.24
시가총액:
$20.67M
수익:
$321.50K
순이익/손실:
$-7.24M
주가수익비율:
-0.7658
EPS:
-1.7498
순현금흐름:
$-5.72M
1주 성능:
+0.75%
1개월 성능:
-4.96%
6개월 성능:
-40.71%
1년 성능:
-3.60%
1일 변동 폭
$1.31
$1.38
1주일 범위
$1.21
$1.38
52주 변동 폭
$1.21
$3.62
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
22211 WEST INTERSTATE-10, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| BIAF | 1.34 | 20.67M | 321.50K | -7.24M | -5.72M | -1.7498 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Zenopa
bioAffinity Technologies Reports Strong Q3 Growth - TipRanks
bioAffinity's CyPath Lung Test Orders Surge 1,300% in 2024, Q3 Revenue Hits $2.4M | BIAF Stock News - StockTitan
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Zenopa
bioAffinity appoints new Chief Science Officer By Investing.com - Investing.com Canada
bioAffinity appoints new Chief Science Officer - Investing.com India
bioAffinity Technologies Appoints William Bauta, Ph.D., as Chief Science Officer - citybiz
BioAffinity Technologies appoints William Bauta, Ph.D. Chief Science Officer - TipRanks
J. Michael Edwards Named CFO at bioAffinity Technologies - MPO-mag
SA company sets the stage for Asian expansion - The Business Journals
bioAffinity’s CyPath Lung Test Now Available to U.S. Veterans - MPO-mag
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Zenopa
bioAffinity secures Japanese patent for lung health test By Investing.com - Investing.com South Africa
BIAFbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan
bioAffinity secures Japanese patent for lung health test - Investing.com
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung | BIAF Stock News - StockTitan
bioAffinity Technologies Closes of $2.6 Million Registered Direct Offering & Concurrent Private Placement - citybiz
WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
SEC Form 424B5 filed by bioAffinity Technologies Inc. - Quantisnow
WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity Technologies Prices of $2.66 Million Registered Direct Offering & Concurrent Private Placement - citybiz
BioAffinity Technologies Down 25% on Stock Sale, Warrant Private Placement - MarketWatch
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity VP contributes to new cytometry guidelines - Investing.com
bioAffinity VP contributes to new cytometry guidelines By Investing.com - Investing.com South Africa
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines - StockTitan
Lung cancer test speeds growth of San Antonio's bioAffinity - Head Topics
New lung cancer test uses phlegm, machine learning to make early diagnoses - San Antonio Express-News
SA biomed to expand military market under new CFO - The Business Journals
bioAffinity Technologies names J. Michael Edwards as CFO - Investing.com India
bioAffinity Technologies names J. Michael Edwards as CFO By Investing.com - Investing.com Australia
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer - citybiz
bioAffinity Technologies Welcomes Back CFO for Future Growth - TipRanks
bioAffinity Technologies Appoints J. Michael Edwards as Chief Financial Officer - TechBullion
bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans - Mugglehead
Maxim Group Initiates Coverage of bioAffinity Technologies (BIAF) with Buy Recommendation - MSN
BioAffinity Technologies : Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test Form 8 K - Marketscreener.com
bioAffinity Technologies Expands Access to Lung Cancer Test - TipRanks
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test - StockTitan
bioAffinity Technologies secures shareholder nod for warrant exercise - Investing.com
bioAffinity Technologies secures shareholder nod for warrant exercise By Investing.com - Investing.com UK
bioAffinity Technologies (NASDAQ:BIAFW) Shares Up 9.3% - Defense World
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - BioSpace
Peer-Reviewed Study: bioAffinity Technologies' CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - Yahoo Finance
BioAffinity Technologies Searching For New Finance Chief - MPO-mag
bioAffinity Technologies Searching for New Finance Chief - MPO-mag
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.04%
3.19%
자본화:
|
볼륨(24시간):